Therapeutic banner
Therapeutic banner

Primary Hyperoxaluria Type 1 (PH1)

View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to PH1.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.

Congresses

Congress-AAIC-Mobile

Primary Hyperoxaluria Type 1 (PH1)

European Renal Association (ERA) 2025

Publications

Primary Hyperoxaluria Type 1 (PH1)

Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study

BMC Nephrology

Author(s)

David Danese, Diana Goss, Carla Romano, et al

Primary Hyperoxaluria Type 1 (PH1)

Quantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials

Bioanalysis

Author(s)

Valerie A Clausen, Karen H Cao, John M Gansner, et al

Primary Hyperoxaluria Type 1 (PH1)

Estimating health state utilities in primary hyperoxaluria type 1: a valuation study

Journal of Medical Economics

Author(s)

Hayley M de Freitas, David Danese, Lena Hubig, et al

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial

Pediatric Nephrology

Author(s)

Wesley Hayes, David J Sas, Daniella Magen, et al

Primary Hyperoxaluria Type 1 (PH1)

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

American Journal of Kidney Diseases

Author(s)

Mini Michael, Jaap W Grothoff, Hadas Shasha-Lavsky, et al

Primary Hyperoxaluria Type 1 (PH1)

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1

Kidney International Reports

Author(s)

Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, et al